Albuterol
- Product NDC
- 59651-334
- 11-digit product format
- 596510334
- Labeler code
- 59651
- Product ID
- 59651-334_f89dffb1-5c4b-48aa-90b4-74043fc9b690
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Albuterol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA213657
- Marketing category
- ANDA
- Marketing start
- 2020-05-14
- Substance
- ALBUTEROL SULFATE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Albuterol
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ALBUTEROL SULFATE | 4 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 021SEF3731 |
| Rxcui | 197316, 197318 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59651-334-01 | Albuterol | 100 in 1 BOTTLE | TABLET | 100 | | 3 |
| 59651-334-05 | Albuterol | 500 in 1 BOTTLE | TABLET | 500 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59651-334 | ALBUTEROL TABLET [AUROBINDO PHARMA LIMITED] | 3 | Current NDC, Legacy NDC, 2 package rows | 20230111_ff9b287b-e4a4-4c12-ad2f-6b7d55b20dc6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59651-334-01 | 59651033401 | 100 TABLET in 1 BOTTLE (59651-334-01) | 100 tablet | 2020-05-14 | 0000-00-00 | No | No | Current |
| 59651-334-05 | 59651033405 | 500 TABLET in 1 BOTTLE (59651-334-05) | 500 tablet | 2020-05-14 | 0000-00-00 | No | No | Current |